(Q34447453)

2 August 2017

1 reference

title

Positron emission tomography (PET) of non-small cell lung cancer (English)

1 reference

positron emission tomography

2 August 2017

1 reference

Haberkorn U

1

1 reference

2 August 2017

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

34 Suppl 2

1 reference

2 August 2017

S115-21

1 reference

Improvement of non-small-cell lung cancer staging by means of positron emission tomography

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Mediastinal staging of non-small-cell lung cancer with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Nuclear medicine procedures in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Emerging role of PET in the diagnosis and staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

[(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Evaluation of primary pulmonary carcinoid tumors using FDG PET

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Elevation of glucose transporter, c-myc, and transin RNA levels by Ha-rasT24 is independent of its effect on the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Transformation stimulates glucose transporter gene expression in the absence of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Characterization of chest masses by FDG positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Localized form of bronchioloalveolar carcinoma: FDG PET findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Selective use of PET scan in the preoperative staging of NSCLC

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Pulmonary abnormalities and PET data analysis: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Prospective investigation of positron emission tomography in lung nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Staging non-small cell lung cancer with whole-body PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

An approach to demonstrating cost-effectiveness of diagnostic imaging modalities in Australia illustrated by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Glucose uptake by gliomas after treatment. A positron emission tomographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Degradation and biosynthesis of the glucose transporter protein in chicken embryo fibroblasts transformed by the src oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Satellite PET and lung cancer: a prospective study in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: comparison with [18F]FDG-PET

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Transformation by the src oncogene alters glucose transport into rat and chicken cells by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

The src oncogene can regulate a human glucose transporter expressed in chicken embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

Over-expression of facilitative glucose transporter genes in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900351-8

7 January 2021

10.1016/S0169-5002(01)00351-8

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11720751